Back to search results

NOURISH-ALL: Healthy Weight Intervention for Families During ALL Treatment

This study is testing an intervention called NOURISH-ALL, which is designed to help families of children with acute lymphoblastic leukemia (ALL) maintain a healthy weight and cope with stress during early treatment. It builds on a previous program for cancer survivors. The study aims to see how well families engage with the NOURISH-ALL program, specifically looking at how many people join, how many stay in the study, and how much of the program they complete. This study is for children aged 2-12 who have ALL, have finished the first phase of treatment (induction), and are not yet in the maintenance phase. Both the child and their primary caregiver must speak English. The study plans to enroll 20 participants.

Study design
This is a single-arm study, meaning everyone receives the NOURISH-ALL intervention. It is a pilot study to test engagement with the program.
What's involved
Participants will take part in a 6-session family intervention and have data collected at three time points: at the start, after the intervention (Week 6), and at a follow-up (Month 6).
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after the intervention ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06050850

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

Not Yet Recruiting
NAAges 2–12InterventionalPrevention
University of Kansas Medical Center
~20 participants
Updated 2026-07-08 on ClinicalTrials.gov
What's tested:NOURISH-ALL

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Recruitment Rate
Measured over Baseline (Week 0)
+2 more outcomes measured

Conditions

ALL, Childhood
Behavior, Health

Explore related trials

Acute Lymphoblastic Leukemia

NCT06050850

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Children's Mercy Kansas City

    Kansas City, Missouristudy coordinator listed

  • University of Kansas Medical Center

    Kansas City, Kansasno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Carolyn Bates, PhD · PRINCIPAL_INVESTIGATOR · University of Kansas Medical Center
  • Keith August, MD · PRINCIPAL_INVESTIGATOR · Children's Mercy Kansas City

Who to contact

Carolyn Bates, PhD
[email protected]
913-588-6323
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Children ages 2-12 years old and their primary caregiver ages 18-90
Child diagnosed with acute lymphoblastic leukemia (ALL)
Child completed induction phase of therapy and not yet in maintenance phase of therapy
Primary caregiver and child English language proficient
Primary caregiver able to provide permission for child to participate in research
Primary caregiver identifies as being involved with child's oncology care
Primary caregiver lives with child at least 50% of the time
Primary oncology provider confirms child is eligible to participate

Exclusion

Primary oncology provider identifies safety concerns regarding the child's participation in the study.

What this trial measures

  • Recruitment RateBaseline (Week 0)

    Measured by # enrolled / # eligible

  • Retention RatePost-Intervention (Week 6), Follow-Up (Month 6)

    Measured by # completed intervention / # enrolled

  • Intended dose receivedPost-Intervention (Week 6), Follow-Up (Month 6)

    Measured by # sessions attended / # sessions offered